Guggenheim started coverage on shares of Tempus AI (NASDAQ:TEM – Free Report) in a research note issued to investors on Monday, Marketbeat reports. The brokerage issued a buy rating and a $74.00 price objective on the stock.
A number of other research firms have also recently commented on TEM. Bank of America cut shares of Tempus AI from a “buy” rating to a “neutral” rating and lifted their price objective for the stock from $45.00 to $60.00 in a research report on Wednesday, October 2nd. Piper Sandler restated a “neutral” rating and set a $70.00 price objective (up previously from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Stifel Nicolaus cut shares of Tempus AI from a “buy” rating to a “hold” rating and boosted their target price for the company from $45.00 to $65.00 in a research report on Monday, November 11th. Finally, Loop Capital boosted their price target on Tempus AI from $48.00 to $57.00 and gave the stock a “buy” rating in a report on Tuesday, October 15th. Three equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat, Tempus AI has a consensus rating of “Moderate Buy” and a consensus price target of $56.20.
View Our Latest Analysis on Tempus AI
Tempus AI Price Performance
Institutional Investors Weigh In On Tempus AI
Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Franklin Resources Inc. lifted its stake in shares of Tempus AI by 1.0% in the third quarter. Franklin Resources Inc. now owns 811,311 shares of the company’s stock valued at $45,920,000 after buying an additional 8,387 shares in the last quarter. Tidal Investments LLC bought a new position in Tempus AI during the third quarter valued at $7,633,000. Teachers Retirement System of The State of Kentucky grew its stake in shares of Tempus AI by 6.3% during the 3rd quarter. Teachers Retirement System of The State of Kentucky now owns 126,500 shares of the company’s stock worth $7,160,000 after acquiring an additional 7,500 shares during the period. Geode Capital Management LLC increased its stake in shares of Tempus AI by 0.4% in the third quarter. Geode Capital Management LLC now owns 133,171 shares of the company’s stock worth $7,537,000 after purchasing an additional 539 shares in the last quarter. Finally, XTX Topco Ltd purchased a new position in Tempus AI in the 3rd quarter valued at approximately $502,000. 24.22% of the stock is owned by institutional investors.
About Tempus AI
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Recommended Stories
- Five stocks we like better than Tempus AI
- Best Stocks Under $5.00
- How to Master Trading Discipline: Overcome Emotional Challenges
- What is the NASDAQ Stock Exchange?
- Does China Investigation Change NVIDIA’s Outlook; Yes, No, Maybe?
- What Are the U.K. Market Holidays? How to Invest and Trade
- Is Marvell Technology Chipping Away at NVIDIA’s Market Lead?
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.